Medicamen enters into domestic pharma
Mumbai: Pharma Major- Medicamen Biotech Ltd is foraying into Domestic Business with its subsidiary Medicamen Life Sciences Pvt Ltd.
While issuing the press release, Medicamen group chairman Mr. Rahul Bishnoi told "The Vision of the Company is to become a most admired Pharmaceutical organization by offering research & data backed, affordable & quality medicines for Indian population and to start with, the company has entered cardio-vascular & Diabetes (CVD) Business, which contributes annual revenue of more than Rs.50000 Crore to IPM with a CAGR of 11%".
Kamal Pahwa, a Pharma Veteran with 32 Year of Experience in CVD business and Pramod Sharma of Neelkanth Drugs Pvt Ltd, a distribution network in India has joined hands with Medicamen to launch this very Ambitious venture, said Mr. Bishnoi. Medicamen Biotech Ltd established in 1996, till now has been focusing on international business. It has recently commenced it's the state of art oncology plant at Haridwar which is meant for regulated market like US and Europe. Medicamen earlier this year has launched its high-quality oncology products in domestic market.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.